Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Supernus Pharmaceuticals Inc (SUPN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Supernus's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
30.07 +0.76    +2.59%
26/04 - Closed. Currency in USD ( Disclaimer )
After Hours
30.07
0.00
0.00%
16:20:00 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 325,059
  • Bid/Ask: 29.27 / 31.58
  • Day's Range: 29.18 - 30.18
Supernus 30.07 +0.76 +2.59%

SUPN Recent Sentiments

 
This page contains information on users’ sentiments for the Supernus Pharmaceuticals Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 08, 2024 Александр Демин   31.68 -5.08%
Sep 06, 2023 Florence Monson   32.13 Nov 30, 2023 @ 26.94 -16.15%
Jul 26, 2022 Florence Monson   31.07 Aug 19, 2022 @ 35.51 +14.29%
Apr 06, 2022 james adama   33.58 Apr 29, 2022 @ 27.90 +16.91%
Nov 30, 2021 Nadir Petrov   29.65 Dec 24, 2021 @ 30.80 +3.88%
Nov 22, 2021 Илья Раров   32.67 Nov 29, 2021 @ 30.31 -7.22%
Nov 18, 2021 Eric Hamon   33.23 Dec 10, 2021 @ 28.89 -13.06%
Nov 02, 2021 Carlos Ahedo   30.29 Nov 08, 2021 @ 33.20 +9.61%
Nov 02, 2021 Alex Surfer   30.08 Nov 05, 2021 @ 32.50 +8.05%
Oct 25, 2021 добрыхдел мастер   29.82 Nov 19, 2021 @ 33.47 +12.24%
Aug 24, 2021 STOICTRADER   24.54 Aug 30, 2021 @ 26.80 +9.21%
Jun 16, 2021 Eric Hamon   34.01 Jul 09, 2021 @ 28.41 -16.47%
Jun 16, 2021 Michele Bertinelli   33.48 Jun 21, 2021 @ 32.62 -2.57%
Jun 09, 2021 Camisoladez Slb   30.51 Jul 02, 2021 @ 30.37 -0.46%
May 12, 2021 Florence Monson   29.73 Jun 04, 2021 @ 29.88 +0.50%
May 04, 2021 Eric Hamon   31.02 May 28, 2021 @ 29.85 -3.77%
Apr 15, 2021 Евгений Стерехов   32.02 May 07, 2021 @ 29.37 -8.28%
Apr 14, 2021 Hanan Alkhamies   31.89 May 07, 2021 @ 29.37 -7.90%
Apr 13, 2021 Daniel Santillán   30.46 May 07, 2021 @ 29.37 -3.58%
Apr 05, 2021 Radu Varga   29.90 Apr 30, 2021 @ 30.45 +1.84%
Apr 05, 2021 Robbert Kuipers   29.60 Apr 12, 2021 @ 27.99 -5.44%
Apr 05, 2021 KA wan Cheang   29.30 Apr 27, 2021 @ 31.89 +8.84%
Mar 17, 2021 Jorge Almeida Pereira   26.19 Apr 09, 2021 @ 28.31 -8.09%
Mar 11, 2021 Серьга Шестаков   26.54 Apr 02, 2021 @ 26.72 +0.68%
Mar 05, 2021 Pedro Gil   24.31 Mar 26, 2021 @ 26.23 +7.90%
Mar 04, 2021 warren klem   24.73 Mar 26, 2021 @ 26.23 +6.07%
Mar 01, 2021 Дмитрий Щербаков   26.29 Mar 26, 2021 @ 26.23 -0.23%
Feb 22, 2021 Илья Петрановский   29.03 Mar 19, 2021 @ 26.14 -9.96%
Feb 18, 2021 Thanh Truong   29.28 Mar 12, 2021 @ 26.70 -8.79%
Feb 01, 2021 Ekaterina Kutnyak   29.61 Feb 26, 2021 @ 26.87 -9.25%
Jan 27, 2021 Aapo Koponen   30.85 Feb 19, 2021 @ 29.61 -4.02%
Jan 26, 2021 Лира Пушкова   30.52 Feb 19, 2021 @ 29.61 -2.98%
Jan 08, 2021 Роман Минаев   27.06 Jan 29, 2021 @ 29.39 +8.61%
Jan 05, 2021 Jorge Almeida Pereira   25.75 Jan 29, 2021 @ 29.39 +14.14%
Jan 04, 2021 Yanko El Toro   24.93 Jan 29, 2021 @ 29.39 +17.89%
Dec 29, 2020 Danil Mishenin   25.21 Jan 22, 2021 @ 29.94 +18.76%
Dec 24, 2020 Filip Schirato   25.65 Jan 15, 2021 @ 29.22 +13.92%
Dec 24, 2020 For youtube Music   25.29 Jan 13, 2021 @ 28.23 +11.63%
Dec 23, 2020 George Lambros   26.34 Jan 15, 2021 @ 29.22 +10.93%
Dec 23, 2020 zvi levy   26.01 Jan 15, 2021 @ 29.22 +12.34%
Dec 15, 2020 Vsevolod Boroda   21.34 Jan 08, 2021 @ 27.26 +27.74%
Dec 09, 2020 Pain Killer   21.64 Jan 01, 2021 @ 25.16 +16.27%
Dec 04, 2020 Renato Alves   21.86 Dec 25, 2020 @ 25.66 +17.38%
Nov 30, 2020 mario simoes   21.54 Dec 25, 2020 @ 25.66 +19.13%
Nov 04, 2020 Sergey Shakirov   22.00 Nov 27, 2020 @ 21.87 -0.59%
Oct 13, 2020 Muhamamd Rizwan...   20.92 Nov 06, 2020 @ 23.61 -12.86%
Oct 08, 2020 호원 김   21.44 Oct 30, 2020 @ 18.33 -14.51%
Sep 29, 2020 Yasmin De los Urriaga   20.62 Oct 23, 2020 @ 20.09 -2.57%
Sep 24, 2020 Влад Влад   20.37 Oct 16, 2020 @ 20.39 +0.10%
Sep 17, 2020 Jacob Armour   22.48 Oct 09, 2020 @ 21.43 +4.67%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SUPN Comments

Write your thoughts about Supernus Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
John Moris
John Moris Mar 02, 2021 1:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good fundamentals, discount price, solid company. Nice price to add @ 25,20?
Josef Kurzmann
Josef Kurzmann Mar 02, 2021 1:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I'm waiting for $20 and maybe $15.
Josef Kurzmann
Josef Kurzmann Mar 02, 2021 1:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
the last earnings report was not good so that should put pressure on the stock price for now (at least until the next earnings report).
John Moris
John Moris Mar 02, 2021 1:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Josef Kurzmann what do you find it was not good in the last report?
Josef Kurzmann
Josef Kurzmann Mar 02, 2021 1:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
declining earnings and revenues compared to the prior quarter.
Josef Kurzmann
Josef Kurzmann Mar 02, 2021 1:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i know if the earnings and revenues decline for 1 quarter it isn't a big thing but what will happen if they decline for 2 or 3 quarters, we would possible see $15
Josef Kurzmann
Josef Kurzmann Feb 23, 2021 9:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i sold a couple of days ago, seems like the real market crash is finally coming. I'll re-visit SUPN in a couple of months and decide if the share price fell deep enough.
Josef Kurzmann
Josef Kurzmann Feb 09, 2021 8:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yesterday i sent this stock as an "tip" to some stock advisors and hedge funds (only about 5 combined). the price rose 4.38% and today it is up 3.39% in the pre-market. i will tell more fund managers about this stock and then the price should jump really quick.
David Bieleski
David Bieleski Feb 09, 2021 8:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
That moment when Josef thinks he is moving markets
Josef Kurzmann
Josef Kurzmann Jan 30, 2021 3:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
one more time:I don't have the knowledge to make an educated guess if the FDA will or will not approve the new ADHD treatment and i am pretty sure you don't have the knowledge and insight eigther.What i know if that SUPN had a great balance sheet, is growing it's revenues 30% per year/earnings 40% per year both since 2016. I also know that their P/E ratio is at 12.5. so i can tell you, even if the new drug doesn't get approved the stock should be at around $90 per share (4.5 billion market cap). Right now it is at $30. If the new drug gets approved it should easily be at $100+ by the end of next year (December 2022) that is a 200%+ return in 23 months.
Hyborian War
HyborianWar Jan 30, 2021 3:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
BBRW
Josef Kurzmann
Josef Kurzmann Jan 29, 2021 8:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
supernus has a great risk/reward ratio. since 2016 earnings and revenues more than doubled yet the stock price is down 50% ($30 as I'm writing) . revenues and earnings are growing very fast (30%/40%p.a.) and this all makes it very likely that this stock quadrouples over the next 3-5 years.
Josef Kurzmann
Josef Kurzmann Jan 29, 2021 8:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
and i didn't even factor in that they have a new revolutionary treatment for ADHD in trial 3 that could be approved by the FDA (then the stock would be worth even more).
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email